Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asako Murayama

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Gastroenterology|January 27, 2019
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver miceAkira Doi, Hayato Hikita, Yugo Kai, et al.
Scientific Reports|September 15, 2015
Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule ExpressionMegumi Tasaka-Fujita, Nao Sugiyama, Wonseok Kang, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosisMohsan Saeed, Masaaki Shiina, Tomoko Date, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 23, 2019
Anti-viral effects of interferon-λ3 on hepatitis B virus infection in cell cultureNorie Yamada, Asako Murayama, Masaaki Shiina, et al.
Plos Pathogens|March 21, 2022
The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitroSameh A Gad, Masaya Sugiyama, Masataka Tsuge, et al.
Journal of Virology|May 13, 2021
MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core PromoterMarwa K Ibrahim, Tawfeek H Abdelhafez, Junko S Takeuchi, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 5, 2021
Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional CureTakashi Honda, Norie Yamada, Asako Murayama, et al.
Biochemical and Biophysical Research Communications|June 15, 2021
Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virusXin Zheng, Rui Guo, Qingbo Liu, et al.
Nature Communications|September 6, 2022
Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigenAyaka Washizaki, Asako Murayama, Megumi Murata, et al.
Hepatology (Baltimore, Md.)|May 24, 2020
N-Terminal PreS1 Sequence Regulates Efficient Infection of Cell-Culture-Generated Hepatitis B VirusAsako Murayama, Norie Yamada, Yoshiki Osaki, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Gastroenterology|January 27, 2019
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver miceAkira Doi, Hayato Hikita, Yugo Kai, et al.
Scientific Reports|September 15, 2015
Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule ExpressionMegumi Tasaka-Fujita, Nao Sugiyama, Wonseok Kang, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosisMohsan Saeed, Masaaki Shiina, Tomoko Date, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 23, 2019
Anti-viral effects of interferon-λ3 on hepatitis B virus infection in cell cultureNorie Yamada, Asako Murayama, Masaaki Shiina, et al.
Plos Pathogens|March 21, 2022
The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitroSameh A Gad, Masaya Sugiyama, Masataka Tsuge, et al.
Journal of Virology|May 13, 2021
MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core PromoterMarwa K Ibrahim, Tawfeek H Abdelhafez, Junko S Takeuchi, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 5, 2021
Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional CureTakashi Honda, Norie Yamada, Asako Murayama, et al.
Biochemical and Biophysical Research Communications|June 15, 2021
Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virusXin Zheng, Rui Guo, Qingbo Liu, et al.
Nature Communications|September 6, 2022
Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigenAyaka Washizaki, Asako Murayama, Megumi Murata, et al.
Hepatology (Baltimore, Md.)|May 24, 2020
N-Terminal PreS1 Sequence Regulates Efficient Infection of Cell-Culture-Generated Hepatitis B VirusAsako Murayama, Norie Yamada, Yoshiki Osaki, et al.
Pageof 5